on Affluent Medical (isin : FR0013333077)
Affluent Medical to Participate in Key Scientific Conferences
Affluent Medical, a French medical technology firm, announced its involvement at significant scientific conferences in late 2024. The company will attend the European Association for Cardio-Thoracic Surgery meeting in Lisbon, the International Continence Society gathering in Madrid, and the PCR London Valves course.
Affluent focuses on developing minimally invasive implants. CEO Sébastien Ladet highlighted advancements like the mitral valve technology partnership with Edwards Lifesciences. Devices like Kalios™ and Epygon aim to innovate mitral valve treatments, while the Artus sphincter seeks to address urinary incontinence.
At these events, Affluent will update on its devices' progress, emphasizing collaboration with medical experts.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Affluent Medical news